Acetylcholinesterase - Amniotic Fluid Test in UAE

Acetylcholinesterase – Amniotic Fluid Test in Dubai and across the UAE to assess fetal neural tube development and detect serious congenital abnormalities such as spina bifida and anencephaly. This specialized test analyzes amniotic fluid for the presence of acetylcholinesterase, a key enzyme linked to open neural tube defects. Results available within 15 days.

Overview

The Acetylcholinesterase (AChE) – Amniotic Fluid Test is a critical prenatal diagnostic tool used to confirm the presence of **open neural tube defects (NTDs)** in the developing fetus. When the spinal cord or brain fails to close properly during early pregnancy, proteins and enzymes like acetylcholinesterase leak into the amniotic fluid. This test detects that enzyme, providing definitive evidence beyond what ultrasound or maternal serum AFP can show. It is typically performed after an abnormal **maternal serum alpha-fetoprotein (MSAFP)** result or suspicious fetal ultrasound findings. Results are processed in specialized labs and available within 15 business days.

Why You Need This Test

• Confirm open neural tube defects such as spina bifida or anencephaly.
• Follow-up after elevated maternal serum AFP (MSAFP) levels.
• Investigate abnormal fetal anatomy seen on level II ultrasound or anomaly scan.
• Differentiate between open and closed NTDs — only open defects release AChE into amniotic fluid.
• Support informed decision-making during high-risk pregnancies.
• Essential for pregnancies with family history of NTDs or maternal folic acid deficiency.
• Performed using amniotic fluid obtained via amniocentesis, available at accredited centers across Dubai, Abu Dhabi, and the UAE.

Symptoms & Risk Factors

Fetal Indicators (Detected via Screening)

• Elevated maternal AFP levels in second-trimester screening
• Abnormal ultrasound findings: “lemon sign” (skull shape), “banana sign” (cerebellum), spinal irregularities
• Polyhydramnios (excess amniotic fluid)
• Low fetal position or breech presentation in later stages

Maternal & Environmental Risk Factors

• Inadequate folic acid intake before and during early pregnancy
• Family history of neural tube defects
• Pre-gestational diabetes (poorly controlled)
• Obesity (BMI >30)
• Use of certain anti-seizure medications (e.g., valproic acid, carbamazepine)
• Hyperthermia (high fever or sauna use) in first trimester
• Exposure to environmental toxins or pesticides

How the Test Works

Acetylcholinesterase is an enzyme normally found in nerve tissue. In cases of **open neural tube defects**, fetal neural tissue is exposed to amniotic fluid, allowing AChE to leak from the central nervous system. Unlike alpha-fetoprotein (AFP), which can be elevated for other reasons, **acetylcholinesterase is highly specific for open NTDs**.

• Step 1 — Amniocentesis: performed by a perinatologist between 15–20 weeks of gestation; a small amount of amniotic fluid is extracted using ultrasound guidance.
• Step 2 — Sample handling: fluid is collected in a sterile container, kept cool, and sent immediately to the lab.
• Step 3 — Laboratory analysis: gel electrophoresis or immunoassay detects the presence of acetylcholinesterase bands.
• Step 4 — Interpretation: a positive AChE band confirms an open neural tube defect.
• Step 5 — Results: detailed report issued within 15 business days.

This test provides crucial diagnostic clarity when ultrasound and blood tests raise concerns.

Sample Type

• We take: Amniotic fluid (minimum 5–10 mL recommended)
• Collection method: transabdominal amniocentesis under ultrasound guidance
• Container: sterile, DNA/RNA-free tube (no preservatives)
• Storage: refrigerated (2–8°C) during transport; no freezing
• Labeling: must include maternal name, gestational age, and date/time of collection
• Note: hemolyzed or contaminated samples may not be analyzable

Risks & Safety

• Procedure risk: amniocentesis carries a small risk of miscarriage (0.1–0.3%).
• Minor discomfort during needle insertion; cramping may occur afterward.
• Leakage of fluid or spotting is rare but possible.
• Infection risk is very low with sterile technique.
• No risk to the baby from the lab test itself — analysis is performed on extracted fluid.
• Recommended only when clinical indications justify the procedure.

Result Interpretation

Normal Result

• Negative for acetylcholinesterase: no enzyme band detected
• Suggests absence of **open neural tube defect**
• May still require correlation with ultrasound and AFP levels

Abnormal Result

• Positive for acetylcholinesterase: clear enzyme band present on electrophoresis
• Highly indicative of an **open neural tube defect**, such as:
  • Spina bifida (myelomeningocele)
  • Anencephaly
  • Encephalocele
• False positives are rare; confirmation with imaging is standard

Borderline or Inconclusive

• Faint or uncertain bands may require repeat analysis or expert review
• Correlation with detailed anomaly scan is essential

Consequences if Undiagnosed

• Spina bifida: can lead to paralysis, bladder/bowel dysfunction, hydrocephalus, and lifelong disability.
• Anencephaly: fatal condition; babies are stillborn or die shortly after birth.
• Lack of prenatal planning: missed opportunity for specialized delivery, neonatal surgery, or informed choices.
• Emotional and psychological impact on families due to unexpected diagnosis at birth.
• Increased risk of preterm birth or cesarean delivery due to fetal malposition.

Factors Affecting Test Results

• Gestational age: testing too early (<15 weeks) may yield false negatives.
• Blood contamination: maternal blood in sample can interfere with analysis.
• Improper storage: delayed refrigeration or freezing damages enzymes.
• Previous intrauterine procedures: such as fetal blood sampling or transfusion.
• Multiple gestation: increases complexity; fluid must be clearly identified per sac.
• Open abdominal wall defects: e.g., gastroschisis or omphalocele, may rarely cause AChE positivity.

FAQs

Limitations

• Only detects open neural tube defects — closed defects (e.g., spina bifida occulta) do not release AChE.
• Requires invasive procedure (amniocentesis) with small miscarriage risk.
• Not a screening test — used only after abnormal initial findings.
• Long turnaround time (15 days) may delay decision-making.
• Results must be interpreted alongside ultrasound, AFP, and clinical context.
• Not widely available — requires specialized lab processing and expertise.

Book the Acetylcholinesterase – Amniotic Fluid Test Today

Get clarity after an abnormal prenatal screening — understand your baby’s health with accurate, lab-confirmed diagnosis.

• Available at Accredited Fetal Medicine Centers in Dubai, Abu Dhabi & Across UAE
• Specialized Lab Analysis for Open Neural Tube Defects
• Price: AED 410 (Amniocentesis procedure billed separately)
• ✅ Expert Interpretation | CLIA-Aligned Labs
• 🔬 High Specificity for Spina Bifida & Anencephaly
• 🔒 Confidential Reporting | Secure Data Handling
• 🕒 Results in 15 Days